Company Filing History:
Years Active: 1999-2008
Title: The Innovative Contributions of Peter Donner
Introduction
Peter Donner is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of cancer research, particularly through his innovative patents. With a total of four patents to his name, Donner's work focuses on the therapeutic and diagnostic applications of apoptin, a protein that plays a crucial role in tumor cell apoptosis.
Latest Patents
One of Peter Donner's latest patents involves modifications of apoptin, specifically the phosphorylated form of the protein. This patent elucidates the tumor-specific phosphorylation of apoptin and its role in the apoptotic pathway within tumor cells. The invention opens up new therapeutic possibilities, including the development of novel therapeutic compounds that can function independently or in conjunction with existing treatments. Additionally, the patent describes the use of tumor-specific phosphorylation of apoptin for diagnostic purposes. This could include methods for detecting cancer cells, identifying cancer-prone cells, or assessing the effects of apoptin on tumor cells by analyzing the phosphorylation state of the protein. Furthermore, the invention aims to enhance the understanding of the apoptotic pathway and identify key mediators of phosphorylation in human tumor cells, which could lead to new anti-cancer therapies.
Career Highlights
Throughout his career, Peter Donner has worked with prominent companies in the pharmaceutical industry, including Schering Aktiengesellschaft and Leadd B.V. His experience in these organizations has contributed to his expertise in cancer research and therapeutic development.
Collaborations
Peter Donner has collaborated with notable colleagues, including Werner Boidol and Wolf-Dieter Schleuning. These partnerships have further enriched his research and innovation in the field.
Conclusion
Peter Donner's contributions to cancer research through his patents on apoptin demonstrate his commitment to advancing therapeutic and diagnostic methods. His work has the potential to significantly impact the treatment and detection of cancer, showcasing the importance of innovation in medical science.